Close Menu

Not So Secret

Just how private is your DNA, asks an article in Salon. The story covers the pros and cons of inadvertently making your DNA public by buying personal genome services, for instance, and how your code might eventually be misused. "The promise of these tests includes drugs that may someday be tailored to treat your illnesses," the story says. "The peril is that your personal data could circulate more widely than you expect." Blaine Bettinger, who is a customer of 23andMe, was interviewed, and he's a bit more optimistic about data handling.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.